Synthesis of N‐Acetyl‐D‐ and ‐L‐Leucine‐13C6 Tool Compounds in Neurodegenerative Disease
Damien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer · 2026
Read Synthesis of N‐Acetyl‐D‐ and ‐L‐Leucine‐13C6 Tool Compounds in Neurodegenerative Disease by Damien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179125.txt.
Description
Damien Crepin and ten co-authors made labeled versions in 2026 of a drug used for a rare child brain disease. The drug is one mirror form of a modified amino acid; its twin form serves as a control. To trace the drug in the body and tell it apart from the body's own supply, the team needed versions built with a heavy form of carbon.
They built both mirror forms with six heavy carbons, plus a lighter tagged form, by a simple chemical step from the raw amino acids. Tests confirmed the products' identity, purity of form, and shelf stability. Such tracers let doctors follow exactly where the drug goes.
Catalog record
| CREATOR | Damien Crepin, Andrew McGown, Dawn Shepherd, Rebecca Braine, Manvendra Sharma, Jordan Nafie, João Gabriel Ribeiro, G Dan Pantoş, Grant Churchill, Frances M Platt, John Spencer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |